ChiCTR‐INR‐17011400.

Study name	The effect of the treatment of idiopathic membranous nephropathy was observed in the treatment of idiopathic membranous nephropathy, and the effect of the treatment on Th17 / Treg
Methods	Study design; parallel, open‐label RCT Study duration: from May 2017 Duration of follow‐up: not reported
Participants	Setting: single centre Country: China Number: group 1 (40); group 2 (40) Sex (M/F): both Inclusion criteria: 18 to 70 years; 24‐hour urine protein is ≥ 3.5 g; SCr < 442 µmol/L; renal biopsy pathology of Sanjia hospital proved to be membranous nephropathy; a combination of the hormone combined immunosuppressant therapy for 3 months was invalid Exclusion criteria: secondary membranous nephropathy; acute and chronic infectious diseases; malignant tumour; severe diabetes, hypertension, and liver dysfunction; pregnancy; mental illness
Interventions	Group 1 Glucocorticoid + tacmox + Chinese medicine Group 2 Glucocorticoid + tacosa treatment
Outcomes	24 hours of urine protein quantification
Starting date	Registration site date last refreshed 14 May 2017
Contact information	liuyongzhidaifu@163.com
Notes	Not yet recruiting